JP Morgan reduced its holdings in Guangzhou Baiyunshan Pharmaceutical Holdings (00874) by approximately 117,500 shares at a price of around HK$18.96 per share.
On November 4th, Citi reduced its holdings of Baiyunshan (00874) by 117,475 shares, with a price of 18.9589 Hong Kong dollars per share, totaling approximately 2.2272 million Hong Kong dollars.
According to the latest data from the Hong Kong Stock Exchange, on November 4th, JP Morgan reduced its holdings of Guangzhou Baiyunshan Pharmaceutical Holdings (00874) by 117,475 shares, at a price of HK$18.9589 per share, with a total amount of approximately HK$2.2272 million. After the reduction, the latest number of shares held is approximately 17.5819 million shares, with a new holding percentage of 7.99%.
Related Articles
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
